Assessing the Effect of Single Injection Infromedial Peribulbar Injection in Lacrimal Duct Intubation Surgery in Adult Patient: Prospective Cohort Study
Sponsor study identifier
interventional
50
1 country
2
Study Start
September 10, 2021
Actual (reported)Primary Completion
November 1, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
November 1, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
infromedial injection of 3 ml local anesthetic drugs and assessing the pain during lacrimal duct intubation and probability of false tracking
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 1, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 4, 2021
Actual (reported)April 26, 2021
Actual (reported)September 10, 2021
Actual (reported)November 1, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
November 1, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Verbal rating scale (VRS) is a 5 point scale from 0 to 4 where 0 is no pain and 4 is unbearable pain
pain scale
during surgery , study will started September 2021 & will end November 2022
surgery satisfaction using yes or no questionnaire
during surgery
Infra- medial injection of local anesthesia mixture
medial canthus injection of the local anesthesia mixture
Group 1: We used a 25G/ 1" length needle to inject 3ml of lidocaine: bupivacaine (1:1) with 30 IU hyaluronic acid, 0.5ml below the inferior punctum in the lower lid medial margin.
: We used a 25G/ 1" length needle to inject 3ml of lidocaine: bupivacaine (1:1) with 30 IU hyaluronic acid classical medial canthal injection
Research Institute of Ophthamology
Giza, 12573, Egypt
Research Institute of Ophthalmology
Giza, Egypt
abeer salem, MD
research institute of ophthalmology
First Submitted
April 4, 2021
First Posted
April 26, 2021
Study Start
September 10, 2021
Actual (reported)Primary Completion
November 1, 2022
Estimated (date passed)Pilot Study of Sucrose to Reduce Pain in Sick Babies
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
November 1, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
September 21, 2022
Record last verified: 2022-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: